Current
Neuro-Oncology


Volume 23 Number 1
January 2021


Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 1, January



Contents


Central nervous system tumors


Gliomas


High-grade gliomas


Low-grade gliomas


Diffuse astrocytic and oligodendroglial tumors


Diffuse Astrocytoma


Anaplastic Astrocytoma


Glioblastoma


Diffuse Midline Glioma


Metastatic tumors



Central nervous system tumors


Ayasoufi K, Pfaller CK, Evgin L, Khadka RH, Tritz ZP, Goddery EN, Fain CE, Yokanovich LT, Himes BT, Jin F, Zheng J, Schuelke MR, Hansen MJ, Tung W, Parney IF, Pease LR, Vile RG, Johnson AJ.
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.
Brain. 2020 Dec 1;143(12):3629-3652.. doi: 10.1093/brain/awaa343. Epub 2020 Nov 30. PMID: 33253355. Laboratory investigation.




Ma Y, Lim DH, Cho H, Lee JW, Sung KW, Yoo KH, Koo HH, Shin HJ, Suh YL.
Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
J Korean Med Sci. 2020 Dec 14;35(48):e405. doi: 10.3346/jkms.2020.35.e405. PMID: 33316857. Clinical study.




Marjańska A, Drogosiewicz M, Dembowska-Bagińska B, Pawińska-WĄsikowska K, Balwierz W, Bobeff K, MŁynarski W, Mizia-Malarz A, Raciborska A, Wysocki M, Styczyński J.
Nivolumab for the Treatment of Advanced Pediatric Malignancies.
Anticancer Res. 2020 Dec;40(12):7095-7100. doi: 10.21873/anticanres.14738 PMID: 33288608 Case series.




Nagtegaal SHJ, David S, Philippens MEP, Snijders TJ, Leemans A, Verhoeff JJC.
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy.
Clin Transl Radiat Oncol. 2021
Jan 1;26:35-41. doi: 10.1016/j.ctro.2020.11.005. Epub 2020 Nov 15. PMID: 33294645. Retrospective analysis.



Gliomas


Jiang H, Deng G, Liu B, Cheng J, Li Y, Tan Y, Wang J, Chen Q.
Analysis of the short-term outcomes and risk factors of seizure relapse in patients with gliomas after antiepileptic drugs withdrawal.
J Clin Neurosci. 2020 Dec 1;82(Pt A):20-25
. doi: 10.1016/j.jocn.2020.09.051. Epub 2020 Nov 1. PMID: 33317732. Retrospective analysis.




Raysi Dehcordi S, Galzio R, Marrone F, Di Vitantonio H, Marzi S, Fasano T, Taddei G, Millimaggi D, Di Cosimo T, Abbate F, Calvisi G, Masciocchi C, Ricci A.
Brain location and tumor biological markers in high and low grade gliomas: our experience.
J Neurosurg Sci. 2020 Dec 15
. doi: 10.23736/S0390-5616.20.05047-X. Epub ahead of print. PMID: 33320464. Retrospective analysis;




Seaman SC, Bathla G, Park BJ, Woodroffe RW, Smith M, Menezes AH, Noeller J, Yamaguchi S, Hitchon PW.
MRI characteristics and resectability in spinal cord glioma.
Clin Neurol Neurosurg. 2021 Jan;200:106321
. doi: 10.1016/j.clineuro.2020.106321. Epub 2020 Oct 19. PMID: 33268194. Retrospective analysis.



High-grade gliomas



Silva da Costa MD, Camargo NC, Dastoli PA, Nicácio JM, Benevides Silva FA, Sucharski Figueiredo ML, Chen MJ, Cappellano AM, Saba da Silva N, Cavalheiro S.
High-grade gliomas in children and adolescents: is there a role for reoperation?
J Neurosurg Pediatr. 2020 Dec 11:1-10
. doi: 10.3171/2020.7.PEDS20389. Epub ahead of print. PMID: 33307529. Retrospective analysis;



Low-grade gliomas



Cacchione A, Lodi M, Carai A, Miele E, Tartaglia M, Megaro G, Del Baldo G, Alessi I, Colafati GS, Carboni A, Boccuto L, Diomedi Camassei F, Catanzaro G, Po A, Ferretti E, Pedace L, Pizzi S, Folgiero V, Pezzullo M, Corsetti T, Secco DE, Cefalo MG, Locatelli F, Mastronuzzi A.
Upfront treatment with mTOR inhibitor everolimus in pediatric Low-Grade gliomas: A Single Center Experience.
Int J Cancer. 2020 Dec 15
. doi: 10.1002/ijc.33438. Epub ahead of print. PMID: 33320972. Case series;




Han Y, Yang Y, Shi ZS, Zhang AD, Yan LF, Hu YC, Feng LL, Ma J, Wang W, Cui GB.
Distinguishing brain inflammation from grade II glioma in population without contrast enhancement: a radiomics analysis based on conventional MRI.
Eur J Radiol. 2021 Jan 1;134:109467
. doi: 10.1016/j.ejrad.2020.109467. Epub 2020 Dec 2. PMID: 33307462. Retrospective analysis.




Mato D, Velasquez C, Gómez E, Marco de Lucas E, Martino J.
Predicting the Extent of Resection in Low-Grade Glioma by Using Intratumoral Tractography to Detect Eloquent Fascicles Within the Tumor.
Neurosurgery. 2021 Feb;88(2):E190-E202
. doi: 10.1093/neuros/nyaa463. Epub 2020 Dec 11. PMID: 33313812. Retrospective analysis.




Watson J, Romagna A, Ballhausen H, Niyazi M, Lietke S, Siller S, Belka C, Thon N, Nachbichler SB.
Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
Radiat Oncol. 2020 Dec 9;15(1):275
. doi: 10.1186/s13014-020-01719-9. PMID: 33298103. Retrospective analysis.



Diffuse astrocytic and oligodendroglial tumors



Diffuse astrocytoma



Alshoabi SA, Alareqi AA, Omer AM, Suliman AG, Daqqaq TS.
Diffuse astrocytoma and the diagnostic dilemma of an unusual phenotype: A case report.
Radiol Case Rep. 2020 Dec 3;16(2):319-326
. doi: 10.1016/j.radcr.2020.11.023. PMID: 33304444. Case report.



Anaplastic astrocytoma



Khaddour K, Harrison N, Govindan A, Campian JL.
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide.
Case Rep Oncol. 2020 Oct 13;13(3):1244-1251
. doi: 10.1159/000509744. PMID: 33250738. Case report.



Glioblastoma



Curtin L, Whitmire P, Rickertsen CR, Mazza GL, Canoll P, Johnston SK, Mrugala MM, Swanson KR, Hu LS.
Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care.
Front Oncol. 2020 Nov 16;10:580750
. doi: 10.3389/fonc.2020.580750. PMID: 33282737. Retrospective analysis.




Elinzano H, Toms S, Robison J, Mohler A, Carcieri A, Cielo D, Donnelly J, Disano D, Vatketich J, Baekey J, Sturtevant A, MacKinnon K, Wood R, Safran H.
Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial.
Am J Clin Oncol. 2021 Feb 1;44(2):49-52
. doi: 10.1097/COC.0000000000000780. Epub 2020 Dec 4. PMID: 33284237. Phase 1 trial;




Huang J, Mehta M.
Can proton therapy reduce radiation-related lymphopenia in glioblastoma?
Neuro Oncol. 2021 Feb;23(2):179-181
. doi: 10.1093/neuonc/noaa273. Epub 2020 Dec 2. PMID: 33263752. Comment.


Mohan R, et al.
Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons.
Neuro Oncol. 2021 Feb;23(2):284-294
. doi: 10.1093/neuonc/noaa182. Epub 2020 Aug 5. PMID: 32750703. Phase 2 trial.




Klein P, Tyrlikova I, Zuccoli G, Tyrlik A, Maroon JC.
Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement.
Cancer Metab. 2020 Nov 9;8(1):24
. doi: 10.1186/s40170-020-00230-9. PMID: 33292598. Prospective study.




Rades D, Witteler J, Leppert J, Schild SE.
Re-Irradiation for Recurrent Glioblastoma Multiforme.
Anticancer Res. 2020 Dec;40(12):7077-7081
. doi: 10.21873/anticanres.14735. Epub 2020 Dec 7. PMID: 33288605. Retrospective analysis.




Stadlbauer A, Kinfe TM, Eyüpoglu I, Zimmermann M, Kitzwoegerer M, Podar K, Buchfelder M, Heinz G, Oberndorfer S, Marhold F.
Tissue hypoxia and alterations in microvascular architecture predict glioblastoma recurrence in humans.
Clin Cancer Res. 2021 Mar;27(6):1641-1649
. doi: 10.1158/1078-0432.CCR-20-3580. Epub 2020 Dec 8. PMID: 33293375. Retrospective analysis.




Tejada S, Becerra-Castro MV, Nuñez-Cordoba J, Díez-Valle R.
Ki-67 Proliferative Activity in the Tumor Margins as a Robust Prognosis Factor in Glioblastoma Patients.
J Neurol Surg A Cent Eur Neurosurg. 2021 Jan;82(1):53-58
. doi: 10.1055/s-0040-1709730. Epub 2020 Dec 1. PMID: 33260244. Prospective study.




Topkan E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, Bolukbasi Y, Pehlivan B, Selek U.
Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
J Immunol Res. 2020 Nov 14;2020:8628540
. doi: 10.1155/2020/8628540. PMID: 33274245. Retrospective analysis.



*

Wu B, Wang W, Wang H, Zou Q, Hu B, Ye L, Hu Y, Xie Y, Huang N, Lan Q, Cheng H, Dong J, Dai X.
Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2.
Front Oncol. 2020 Nov 16;10:566599
. doi: 10.3389/fonc.2020.566599. PMID: 33312949. Laboratory investigation.




Zhang M, Li R, Pollom EL, Amini A, Dandapani S, Li G.
Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.
J Clin Neurosci. 2020 Dec 1;82(Pt A):122-127
. doi: 10.1016/j.jocn.2020.10.049. Epub 2020 Nov 6. PMID: 33317719. Retrospective analysis.



Diffuse midline glioma



Dono A, Takayasu T, Ballester LY, Esquenazi Y.
Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
J Clin Neurosci. 2020 Dec 1;82(Pt A):1-8
. doi: 10.1016/j.jocn.2020.10.005. Epub 2020 Nov 1. PMID: 33317715. Retrospective analysis.




Rasool MT, Dar IA, Banday SZ, Banday AZ, Chibber SS, Choh NA, Baba MH, Lone MM.
Modality of Radiotherapy and Overall Survival in Pediatric Diffuse Brainstem Gliomas: Implications for Resource-Constrained Settings.
J Trop Pediatr. 2021 Feb;67(1):fmaa105
. doi: 10.1093/tropej/fmaa105. Epub 2020 Dec 5. PMID: 33280037. Retrospective analysis.



Metastatic tumors


Hanyu T, Fujitani S, Ito A, Mizutani N.
Brain metastasis from extramammary Paget's disease.
Nagoya J Med Sci. 2020 Nov;82(4):791-798
. doi: 10.18999/nagjms.82.4.791. PMID: 33311809. Case report.

af-m


bottom

***********************